Sitagliptin treatment reduced melanoma growth in mice as a result of delayed chemokine processing [52], prolonged survival, and increased CD8+ T cell trafficking in a syngeneic ovarian cancer mouse model, highlighting the importance of DPP4 in the regulation of the immune landscape [51]. Here, DPP4 is linked to ovarian carcinoma.